KGISL Completes Acquisition of AETINS, Expands Expertise in the Insurance Space

KG Information Systems Private Limited (KGISL), a global IT services, consulting, and business solution provider, today announced the acquisition of AETINS Sdn. Bhd. through...

Kindstar Globalgene Proposed Listing on the Main Board of the Hong Kong Stock Exchange

Offer Price Between HK$8.60 and HK$9.78 per Share To Raise Proceeds Up to HK$1,947 and 2,214 Million A leading player in China's independent esoteric clinical testing...

China Biotech (8037.HK): Anticipating promising results from cell therapy and from precision diagnostics

2021-6-23 / Gelonghui - China Biotech's cell therapy was approved by the NMPA to enter Phase I clinical trials as a Class I new...

Avance Clinical Appoints Asia Biotech Specialist to Support APAC Growth

Avance Clinical, the leading Australian CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient, announced the appointment of Andy...

Avantor Named Best Company in Bioprocessing Excellence for Single-use Solutions and Best Bioprocessing Supplier...

Avantor, a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies and applied materials industries, was...

Malaysia Permission Granted for COVID-19 Test Kit from China for Emergency Use; Homegrown Holista...

Amid rising concerns over the threat and economic impact of COVID-19, Holista Colltech Ltd (Holista) has been granted permission for special access under the...

Dingdang Health raises US$220 million in new financing round

China's leading integrated online healthcare platform Dingdang Health announced today that it has raised US$220 million in its latest financing round. This round was...

Avance Clinical’s USA Biotech Survey Finds 21% Not Aware Australian Clinical Data is Accepted...

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results of their Australian...

Avantor Acquires RIM Bio; Expands Bioproduction Footprint into China

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied...

Sino Biopharmaceutical 2021 First Quarterly Profit attributable to Owners of the Parent Soars 118.5%...

Contribution of Sales of New Products to Revenue Rises to 47.4% Driving Revenue Up by 16.4% Sino Biopharmaceutical Limited (Sino Biopharmaceutical or the Company, together with...

Two Products of Zhaoke Ophthalmology (6622.HK) Passed The On-Site Inspection for Drug Registration of...

Signifying Government Recognition in The Company's Quality Manufacturing System Zhaoke Ophthalmology Limited (stock code: 6622), an ophthalmic pharmaceutical company dedicated to the research, development and...

Agilex Biolabs Partners with Endpoints News on Deconvoluting Inflammation and Immunology for Clinical Trials

Agilex Biolabs, Australia's largest and most technologically advanced specialist bioanalytical laboratory for clinical trials is partnering with Endpoints News to share the latest on...

APOLLOMICS INC. ANNOUNCES OFFICIAL OPENING OF SHANGHAI BRANCH

Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced that Apollomics Shanghai Branch...

USFDA recognized Antrodia cinnamomea mycelia (NDIN No.1170)

USFDA NDI notification of Antromax "Antrodia cinnamomea mycelia" The history of Antrodia cinnamomea consumption by indigenous tribes in Taiwan dates back two hundred years ago, while...

Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical, has expanded its gene technology clinical...

Agilex Biolabs and B2S Life Sciences on Immunoassay Bioanalysis for Clinical Trials

Agilex Biolabs, Australia's largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, and B2S Life Sciences, a biotherapeutic enablement company advancing improved...

Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives to...

Scivita Medical Technology Co., Ltd. ("civita Medical) today announced that it has raised nearly RMB0.4 Billion in Series A funding round, which has become...

Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China –...

Hua Medicine (Stock Code: 2552.HK), today announced that the New Drug Application (NDA) for dorzagliatin for the treatment of Type 2 Diabetes (T2D) was...

Avance Clinical Invited to Present “Decentralized Trials – No Going Back” for Oracle Health...

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been invited to present on...

Sanofi Renews Partnership with Cielo to Strengthen its Talent Acquisition Strategy in Asia

Cielo, the world's leading Recruitment Process Outsourcing (RPO) provider, has renewed its partnership with Sanofi, a global biopharmaceutical company, to help them hire the...